Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:14:52 UTC |
---|
HMDB ID | HMDB0000474 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Butanone |
---|
Description | Butanone, also known as aethylmethylketon or methyl acetone, belongs to the class of organic compounds known as ketones. These are organic compounds in which a carbonyl group is bonded to two carbon atoms R2C=O (neither R may be a hydrogen atom). Ketones that have one or more alpha-hydrogen atoms undergo keto-enol tautomerization, the tautomer being an enol. Thus, butanone is considered to be an oxygenated hydrocarbon. Butanone is an acetone, camphor, and ethereal tasting compound. Butanone is found, on average, in the highest concentration within milk (cow) and peppermints (Mentha X piperita). Butanone has also been detected, but not quantified in, several different foods, such as japanese chestnuts (Castanea crenata), saskatoon berries (Amelanchier alnifolia), red onion, almonds (Prunus dulcis), and burbots (Lota lota). This could make butanone a potential biomarker for the consumption of these foods. Butanone is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Butanone, with regard to humans, has been found to be associated with several diseases such as crohn's disease, pervasive developmental disorder not otherwise specified, asthma, and ulcerative colitis; butanone has also been linked to the inborn metabolic disorder celiac disease. Based on a literature review a significant number of articles have been published on Butanone. |
---|
Structure | InChI=1S/C4H8O/c1-3-4(2)5/h3H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
2-Butanon | ChEBI | 2-Butanone | ChEBI | 3-Butanone | ChEBI | Aethylmethylketon | ChEBI | Butanone 2 | ChEBI | C2H5COCH3 | ChEBI | Ethyl methyl cetone | ChEBI | Ethyl methyl ketone | ChEBI | Ethyl(methyl) ketone | ChEBI | Ethylmethyl ketone | ChEBI | Ethylmethylketon | ChEBI | Meetco | ChEBI | MEK | ChEBI | Methyl acetone | ChEBI | Methyl ethyl cetone | ChEBI | Methyl ethyl ketone | ChEBI | Methyl(ethyl) ketone | ChEBI | Methylacetone | ChEBI | Methylethyl ketone | ChEBI | Methylethylketon | ChEBI | Oxobutane | ChEBI | Butan-2-one | Kegg | Butanone | ChEBI |
|
---|
Chemical Formula | C4H8O |
---|
Average Molecular Weight | 72.1057 |
---|
Monoisotopic Molecular Weight | 72.057514878 |
---|
IUPAC Name | butan-2-one |
---|
Traditional Name | methyl(ethyl) ketone |
---|
CAS Registry Number | 78-93-3 |
---|
SMILES | CCC(C)=O |
---|
InChI Identifier | InChI=1S/C4H8O/c1-3-4(2)5/h3H2,1-2H3 |
---|
InChI Key | ZWEHNKRNPOVVGH-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as ketones. These are organic compounds in which a carbonyl group is bonded to two carbon atoms R2C=O (neither R may be a hydrogen atom). Ketones that have one or more alpha-hydrogen atoms undergo keto-enol tautomerization, the tautomer being an enol. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbonyl compounds |
---|
Direct Parent | Ketones |
---|
Alternative Parents | |
---|
Substituents | - Ketone
- Organic oxide
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | -86.6 °C | Not Available | Boiling Point | 78.60 to 80.00 °C. @ 760.00 mm Hg | The Good Scents Company Information System | Water Solubility | 223 mg/mL | Not Available | LogP | 0.29 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Butanone,1TMS,isomer #1 | CC=C(C)O[Si](C)(C)C | 846.3 | Semi standard non polar | 33892256 | Butanone,1TMS,isomer #1 | CC=C(C)O[Si](C)(C)C | 793.3 | Standard non polar | 33892256 | Butanone,1TMS,isomer #1 | CC=C(C)O[Si](C)(C)C | 897.6 | Standard polar | 33892256 | Butanone,1TMS,isomer #2 | C=C(CC)O[Si](C)(C)C | 776.6 | Semi standard non polar | 33892256 | Butanone,1TMS,isomer #2 | C=C(CC)O[Si](C)(C)C | 809.5 | Standard non polar | 33892256 | Butanone,1TMS,isomer #2 | C=C(CC)O[Si](C)(C)C | 901.3 | Standard polar | 33892256 | Butanone,1TBDMS,isomer #1 | CC=C(C)O[Si](C)(C)C(C)(C)C | 1040.5 | Semi standard non polar | 33892256 | Butanone,1TBDMS,isomer #1 | CC=C(C)O[Si](C)(C)C(C)(C)C | 1007.9 | Standard non polar | 33892256 | Butanone,1TBDMS,isomer #1 | CC=C(C)O[Si](C)(C)C(C)(C)C | 1095.7 | Standard polar | 33892256 | Butanone,1TBDMS,isomer #2 | C=C(CC)O[Si](C)(C)C(C)(C)C | 1003.6 | Semi standard non polar | 33892256 | Butanone,1TBDMS,isomer #2 | C=C(CC)O[Si](C)(C)C(C)(C)C | 1022.7 | Standard non polar | 33892256 | Butanone,1TBDMS,isomer #2 | C=C(CC)O[Si](C)(C)C(C)(C)C | 1102.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Butanone EI-B (Non-derivatized) | splash10-0006-9000000000-6d2b5f585a1d1bc5a8fb | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Butanone EI-B (Non-derivatized) | splash10-0006-9000000000-9d38ccb9b91100a7ec9a | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Butanone EI-B (Non-derivatized) | splash10-0006-9000000000-c956d364a703ad576f74 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Butanone EI-B (Non-derivatized) | splash10-0006-9000000000-6d2b5f585a1d1bc5a8fb | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Butanone EI-B (Non-derivatized) | splash10-0006-9000000000-9d38ccb9b91100a7ec9a | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Butanone EI-B (Non-derivatized) | splash10-0006-9000000000-c956d364a703ad576f74 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Butanone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9000000000-4e6c1888a6b9f92a7e0c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Butanone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0006-9000000000-389580382a5be690811f | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Butanone Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-05fr-9000000000-ce6384a82cdbc3c32131 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Butanone Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-05fr-9000000000-d2220466d540748715a6 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Butanone Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-00di-9000000000-5c396f6150d62df63bf8 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Butanone EI-B (HITACHI RMU-7M) , Positive-QTOF | splash10-0006-9000000000-342b15824555f25c17ae | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Butanone EI-B (HITACHI M-80B) , Positive-QTOF | splash10-0006-9000000000-9d38ccb9b91100a7ec9a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Butanone EI-B (HITACHI M-80) , Positive-QTOF | splash10-0006-9000000000-c956d364a703ad576f74 | 2012-08-31 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 10V, Positive-QTOF | splash10-05fr-9000000000-df1c4f4393ad8e083cee | 2015-05-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 20V, Positive-QTOF | splash10-0ab9-9000000000-5db9dc68e554d23fe4ca | 2015-05-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 40V, Positive-QTOF | splash10-0a4i-9000000000-e76aaa16e1218b6b92e0 | 2015-05-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 10V, Positive-QTOF | splash10-05fr-9000000000-df1c4f4393ad8e083cee | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 20V, Positive-QTOF | splash10-0ab9-9000000000-5db9dc68e554d23fe4ca | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 40V, Positive-QTOF | splash10-0a4i-9000000000-e76aaa16e1218b6b92e0 | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 10V, Negative-QTOF | splash10-00di-9000000000-75ee4bf0cca979df2fee | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 20V, Negative-QTOF | splash10-00di-9000000000-a0882d603db69a60cd2b | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 40V, Negative-QTOF | splash10-0pb9-9000000000-2b71687b4480da0a40a8 | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 10V, Negative-QTOF | splash10-00di-9000000000-75ee4bf0cca979df2fee | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 20V, Negative-QTOF | splash10-00di-9000000000-a0882d603db69a60cd2b | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 40V, Negative-QTOF | splash10-0pb9-9000000000-2b71687b4480da0a40a8 | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 10V, Positive-QTOF | splash10-0a4i-9000000000-1924391f943e092b4486 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 20V, Positive-QTOF | splash10-0a4i-9000000000-b1f7b08e06d7bb20906d | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 40V, Positive-QTOF | splash10-052o-9000000000-d0609c2afd15f75e6cbb | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 10V, Negative-QTOF | splash10-00di-9000000000-77e5dcf17bd83eca2c67 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 20V, Negative-QTOF | splash10-00dl-9000000000-91a2cd469019aa3b0b9c | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butanone 40V, Negative-QTOF | splash10-0006-9000000000-fa8f185babb9571dbb91 | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Disease References | Alcoholism |
---|
- Jones AW, Lund M, Andersson E: Drinking drivers in Sweden who consume denatured alcohol preparations: an analytical-toxicological study. J Anal Toxicol. 1989 Jul-Aug;13(4):199-203. [PubMed:2779169 ]
| Asthma |
---|
- Ibrahim B, Basanta M, Cadden P, Singh D, Douce D, Woodcock A, Fowler SJ: Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax. 2011 Sep;66(9):804-9. doi: 10.1136/thx.2010.156695. Epub 2011 Jul 11. [PubMed:21749985 ]
| Ulcerative colitis |
---|
- Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21. [PubMed:17314143 ]
- De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8. [PubMed:24811995 ]
- Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25. [PubMed:26806034 ]
| Nonalcoholic fatty liver disease |
---|
- Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, Bailey J, Myers RP, Rioux KP: Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3. doi: 10.1016/j.cgh.2013.02.015. Epub 2013 Feb 27. [PubMed:23454028 ]
| Autism |
---|
- De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R: Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013 Oct 9;8(10):e76993. doi: 10.1371/journal.pone.0076993. eCollection 2013. [PubMed:24130822 ]
| Pervasive developmental disorder not otherwise specified |
---|
- De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R: Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013 Oct 9;8(10):e76993. doi: 10.1371/journal.pone.0076993. eCollection 2013. [PubMed:24130822 ]
| Crohn's disease |
---|
- De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8. [PubMed:24811995 ]
- Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25. [PubMed:26806034 ]
| Celiac disease |
---|
- Francavilla R, Ercolini D, Piccolo M, Vannini L, Siragusa S, De Filippis F, De Pasquale I, Di Cagno R, Di Toma M, Gozzi G, Serrazanetti DI, De Angelis M, Gobbetti M: Salivary microbiota and metabolome associated with celiac disease. Appl Environ Microbiol. 2014 Jun;80(11):3416-25. doi: 10.1128/AEM.00362-14. Epub 2014 Mar 21. [PubMed:24657864 ]
- Di Cagno R, De Angelis M, De Pasquale I, Ndagijimana M, Vernocchi P, Ricciuti P, Gagliardi F, Laghi L, Crecchio C, Guerzoni ME, Gobbetti M, Francavilla R: Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 2011 Oct 4;11:219. doi: 10.1186/1471-2180-11-219. [PubMed:21970810 ]
| Perillyl alcohol administration for cancer treatment |
---|
- Silva CL, Passos M, Camara JS: Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--a powerful strategy for breast cancer diagnosis. Talanta. 2012 Jan 30;89:360-8. doi: 10.1016/j.talanta.2011.12.041. Epub 2011 Dec 22. [PubMed:22284503 ]
|
|
---|
General References | - Weddle DL, Tithoff P, Williams M, Schuller HM: Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis. 2001 Mar;22(3):473-9. [PubMed:11238189 ]
- Goldsmith LB, Friberg SE, Wahlberg JE: The effect of solvent extraction on the lipids of the stratum corneum in relation to observed immediate whitening of the skin. Contact Dermatitis. 1988 Nov;19(5):348-50. [PubMed:3233954 ]
- Carmella SG, Akerkar S, Hecht SS: Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res. 1993 Feb 15;53(4):721-4. [PubMed:8428352 ]
- Stich HF, Parida BB, Brunnemann KD: Localized formation of micronuclei in the oral mucosa and tobacco-specific nitrosamines in the saliva of "reverse" smokers, Khaini-tobacco chewers and gudakhu users. Int J Cancer. 1992 Jan 21;50(2):172-6. [PubMed:1730509 ]
- Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H: Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis. 1985 Feb;6(2):295-303. [PubMed:3971493 ]
- Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE: Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst. 1997 Jun 18;89(12):868-73. [PubMed:9196253 ]
- Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, Hatsukami DK: Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res. 2002 Jan 1;62(1):129-34. [PubMed:11782369 ]
|
---|